Clinical Trial

Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment

Study acronym: G3
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes (T2D).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-12; most recent amendment 2026-03-25.
Trial Details
NCT Number NCT07477249
Lead Sponsor David S Black, PhD
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions Prediabetes
Enrollment 50 participants
Start Date 2026-02-26
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-30